Piper Longum's Neuroprotective Role Against Amyloid-β and Okadaic Acid-Induced Toxicity in U87MG Cells Through the Lipocalin-2 Pathway

Objectives: Alzheimer's disease (AD) is a neurological disorder that causes symptoms such as cognitive impairment and memory loss. The number of AD patients keeps escalating throughout the world leading to various social problems, meanwhile no practical treatment for the disease has been propos...

Full description

Bibliographic Details
Published in:	Journal of Pharmacopuncture
Main Authors:	Seok-Hwan Sung, Seung-Min Shin, Yunna Kim, Seung-Hun Cho
Format:	Article
Language:	English
Published:	Korean Pharmacopuncture Institute 2025-06-01
Subjects:	alzheimer's disease amyloid β astrocyte tau protein lcn2 piper longum
Online Access:	http://www.journal-jop.org/journal/view.html?doi=10.3831/KPI.2025.28.2.92

Similar Items

Dataset of De Novo hybrid berry transcriptome profiling and characterization of Piper species (Piper nigrum and Piper longum) using Illumina and Nanopore sequencing
by: Johnson K. George, et al.
Published: (2022-06-01)

Comparative evaluation of the potential anti-spasmodic activity of Piper longum, Piper nigrum, Terminalia bellerica, Terminalia chebula, and Zingiber officinale in experimental animals
by: Bansilal R. Tiwari, et al.
Published: (2023-09-01)

A pilot clinical study of an add-on Ayurvedic formulation containing Tinospora cordifolia and Piper longum in mild to moderate COVID-19
by: Sushila Kataria, et al.
Published: (2022-04-01)

Molecular docking, drug-likeness properties, and toxicity prediction of alkaloidal phytoconstituents of piper longum against monoamine oxidase enzyme-A as an anti-depressive agent
by: Santosh Prasad Chaudhary kurmi, et al.
Published: (2025-05-01)

Isolation and characterization of acetylcholinesterase inhibitors from Piper longum L.
by: Z. Khatami*, et al.
Published: (2017-11-01)

De novo transcriptome profiling revealing genes involved in piperine biosynthetic pathway in Piper longum L
by: Mrinalini Prasad, et al.
Published: (2025-01-01)

Multi-omics analysis reveals ACOT1 as the key target of piperine in Piper Longum-mediated gastric cancer treatment
by: Boyu Pan, et al.
Published: (2025-08-01)

Assessment of Piper longum L. (Piperaceae) leaves toxicity on the adults of Tribolium castaneum (Herbst, 1797) (Coleoptera: Tenebrionidae)
by: Justin Kumar, et al.
Published: (2024-09-01)

Adulticidal activity against Stegomyia aegypti (Diptera: Culicidae) of three Piper spp.
by: Wej Choochote, et al.
Published: (2006-02-01)

Biogenic silver nanoparticles synthesized from Piper longum fruit extract inhibit HIF-1α/VEGF mediated angiogenesis in prostate cancer cells
by: Süleyman İlhan, et al.
Published: (2021-06-01)

Antibacterial, antibiofilm, and wound healing activities of Piper longum root in multidrug-resistant Staphylococcus aureus infected mice
by: Pooja Gaur, et al.
Published: (2025-05-01)

Retrofractamide C Derived from <i>Piper longum</i> Alleviates Xylene-Induced Mouse Ear Edema and Inhibits Phosphorylation of ERK and NF-κB in LPS-Induced J774A.1
by: Hyung Jin Lim, et al.
Published: (2020-09-01)

Network analysis, in vivo, and in vitro experiments identified the mechanisms by which Piper longum L. [Piperaceae] alleviates cartilage destruction, joint inflammation, and arthritic pain
by: Hee Geun Jo, et al.
Published: (2024-01-01)

SIRT1 Activation by Lignans Identified via UPLC-qTOF-MS/MS-Based Metabolomic Profiling of <i>Piper longum</i> L. Fruit (Long Pepper)
by: Van-Hieu Mai, et al.
Published: (2025-10-01)

Exploring the pharmacological action mechanism of Ligusticum Chuanxiong-Piper Longum couplet medicines on the treatment of migraine based on network pharmacology
by: Ti Li, et al.
Published: (2022-09-01)

Identification of anti-fibrotic compounds from Piper longum L via hollow fiber cell fishing and high-performance liquid chromatography with in vivo and in vitro validation
by: Jie Tian, et al.
Published: (2025-08-01)

Anti-inflammatory effect of Piper longum L. fruit methanolic extract on lipopolysaccharide-treated RAW 264.7 murine macrophages
by: Uyen Thi Tu Phan, et al.
Published: (2024-02-01)

Bioenhancers: Revolutionary concept to market
by: Navin Atal, et al.
Published: (2010-01-01)

A Review of Bioactive Compounds and Antioxidant Activity Properties of <i>Piper</i> Species
by: Nono Carsono, et al.
Published: (2022-10-01)

Amelioration of cyclophosphamide-induced DNA damage, oxidative stress, and hepato- and neurotoxicity by Piper longum extract in rats: The role of γH2AX and 8-OHdG
by: Vaishali Yadav, et al.
Published: (2023-03-01)

The interaction of lipocalin-2 and astrocytes in neuroinflammation: mechanisms and therapeutic application
by: Qianqian Tan, et al.
Published: (2024-03-01)

Neuroprotective effects of Cubebin and Hinokinin lignan fractions of Piper cubeba fruit in Alzheimer’s disease in vitro model
by: Tarbiat Shirin, et al.
Published: (2023-06-01)

Probiotic Characteristics of Human-Residential Bifidobacterium longum subsp. longum Strains
by: WANG Mingfang, CHEN Lilan, ZHANG Xueling, TIAN Fengwei, NI Yongqing
Published: (2024-01-01)

Modulatory impact of Bifidobacterium longum subsp. longum BL21 on the gut–brain–ovary axis in polycystic ovary syndrome: insights into metabolic regulation, inflammation mitigation, and neuroprotection
by: Yao Dong, et al.
Published: (2025-02-01)

Multi-omics analyses the effect of Bifidobacterium longum subsp. longum BL21 supplementation on overweight and obese subjects: a randomized, double-blind, placebo-controlled study
by: Xiaoya Wang, et al.
Published: (2025-07-01)

Development and Characterization of Liposomal Phytoformulation of Piper longum L. for Melanoma Therapy
by: Himani ., et al.
Published: (2025-07-01)

Lipocalin-2-mediated astrocyte pyroptosis promotes neuroinflammatory injury via NLRP3 inflammasome activation in cerebral ischemia/reperfusion injury
by: Juanji Li, et al.
Published: (2023-06-01)

Efficacy of Bifidobacterium longum alone or in multi-strain probiotic formulations during early life and beyond
by: Susan Mills, et al.
Published: (2023-12-01)

Ginkgo biloba Extract Inhibits Astrocytic Lipocalin-2 Expression and Alleviates Neuroinflammatory Injury via the JAK2/STAT3 Pathway After Ischemic Brain Stroke
by: Yehao Zhang, et al.
Published: (2018-05-01)

Inhibition of the mitochondrial pyruvate carrier in astrocytes reduces amyloid and tau accumulation in the 3xTgAD mouse model of Alzheimer's disease
by: Kelly Ceyzériat, et al.
Published: (2024-10-01)

Effects of <i>Bifidobacterium longum longum</i> 35624® on the Symptoms and Quality of Life in Patients with Irritable Bowel Syndrome: Results of the Multicenter Observational Program SAGA
by: V. T. Ivashkin, et al.
Published: (2024-12-01)

Increased Lipocalin 2 detected by RNA sequencing regulates apoptosis and ferroptosis in COPD
by: Ruiying Wang, et al.
Published: (2024-10-01)

Lipocalin-2 is an anorexigenic signal in primates
by: Peristera-Ioanna Petropoulou, et al.
Published: (2020-11-01)

Selection and in vitro Probiotic Properties of Bifidobacterium longum subsp. longum with Anti-diabetic Activity from the Intestinal Tract of Chinese Tajik Children
by: LI Si, AN Meiling, LI Longlong, ZHANG Ruirui, SUN Hailong, NI Yongqing
Published: (2025-05-01)

Interleukin-3 is associated with sTREM2 and mediates the correlation between amyloid-β and tau pathology in Alzheimer’s disease
by: Zhi-Bo Wang, et al.
Published: (2022-12-01)

Long-term colonization exceeding six years from early infancy of Bifidobacterium longum subsp. longum in human gut
by: Kaihei Oki, et al.
Published: (2018-12-01)

Deciphering the impact and mechanism of Trikatu, a spices-based formulation on alcoholic liver disease employing network pharmacology analysis and in vivo validation
by: Ruchi Sharma, et al.
Published: (2022-11-01)

Comparative Genomic Analysis of Novel <i>Bifidobacterium longum</i> subsp. <i>longum</i> Strains Reveals Functional Divergence in the Human Gut Microbiota
by: Romina Díaz, et al.
Published: (2021-09-01)

Unique strain of Bifidobacterium longum and its efficacy in irritable bowel syndrome
by: E. Yu. Plotnikova
Published: (2021-01-01)

Exploring the therapeutic potential of Bifidobacterium longum subsp. longum CCFM1029 in Parkinson's disease: Insights from behavioral, neurophysiological, gut microbiota, and microbial metabolites analysis
by: Tiantian Li, et al.
Published: (2024-10-01)